epiClinicalA fictional CRO

epiClinical is fictional. It is a portfolio demonstration by Adam Daniels. Its studies, sponsors, sites and enrolment figures are synthetic. The evidence behind its assumptions is real, and every number says how far it can be trusted.

Risk monitor

What could slow our studies down, and where?

The risks across every running study: recruitment, the KRIs and QTLs that watch it, and the regional shocks that can hit it from outside.

Risk across the running studies on September 30th 2026

  • QTLs needing a decision1outside or close to their limit
  • Sites over a KRI threshold52of 432 sites with data
  • Waiting too long for a first patient13open sites
  • High risks in the registers23across the running studies
Each running study's recruitment, KRI and QTL risk, and its sites with flags
Show sitesStudyEnrolmentSitesKRIsQTLsWaiting for a first patientHigh risks
EPI-301Non-small cell lung cancer, second line82% of plan5 of 10 behind19 of 159 flaggedAll 4 within–6
EPI-214Heart failure with reduced ejection fraction91% of plan60 of 113 behind33 of 120 flagged1 of 4 outside134
EPI-118Treatment-resistant major depressive disorderToo earlyToo early0 of 135 flaggedToo early–9
EPI-405A rare inherited neuromuscular disorder (genetically confirmed)47% of planToo early0 of 18 flaggedToo early–4

Expand a study to see the sites behind its flags; a status or a count opens the tab behind it. Every colour comes from a threshold in the data with its basis, listed on the References page.